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SUMMARY 
Previous studies have demonstrated circadian fluctuations of systemic catecholamines in man. 
However, methodological differences and conflicting results with epinephrine are apparent. In the 
present study, plasma and urinary epinephrine and norepinephrine and plasma cortisol were 
studied in healthy young adult males over 24 hr with 20 min plasma sampling and EEG monitoring 
of sleep. Plasma epinephrine did not have a circadian variation in supine subjects. Urinary 
epinephrine levels and small urinary circadian variations were increased by normal posture and 
activity. Sleep and sleep stage were not associated with different plasma epinephrine levels, and no 
ultradian fluctuation was observed. Levels of norepinephrine and cortisol were normal. Based on 
all studies to date, it appears that basal plasma epinephrine has either a very small amplitude or no 
circadian rhythm, but that changes in posture and activity or the rest/activity cycle may modify 
this pattern. 
INTRODUCTION 
CIRCADIAN rhythmic fluctuations of physiological functions are ubiquitous from single- 
celled organisms to man. Among these are the rhythms of the systemic catecholamines 
epinephrine and norepinephrine. Control of catecholamines is of particular 
psychoendocrinological interest because of the changes in levels associated with stress and 
anxiety (Frankenhauser, 1971; Rose, 1980; Ward et al., 1983). 
Urinary catecholamine levels in man fluctuate over 24 hr, with highest levels during the 
day (Karki, 1956; Froberg et al., 1972; Townshend & Smith, 1973; Linsell et al., 1985). 
However, only two studies used healthy subjects who maintained supine posture 
throughout. One study (Faucheux et al., 1976) demonstrated a maximum level of both 
epinephrine and norepinephrine between 0830 hr and 2030 hr. In the second study (Ratge 
et al., 1982), highest levels for both catecholamines were at 0800 h r -  1000 hr, with lowest 
levels at 0200 hr -0400  hr. 
Circadian fluctuations of plasma catecholamines also have been studied (Turton & 
Deegan, 1974; Prinz et al., 1979, 1984; Barnes et al., 1980; Mullen et al., 1981; Linsell et 
al., 1985). Four studies that used healthy subjects who maintained a supine posture 
considered norepinephrine (Aronow et al., 1978; Stene et al., 1980; Winer et al., 1980; 
¶Correspondence to: Dr Oliver G. Cameron, Department of Psychiatry, University of Michigan Hospitals, 
Ann Arbor, MI 48109, U.S.A. 
41 
42 ()1 U\ER (.i. ( ' \ME.  Rt)N el tl/. 
Ratge et al., 1982). Significant variations were observed, with the peak in the morning and 
the trough during the later part of sleep. 
Unlike norepinephrine, the presence of  a circadian rhythm of  basal plasma epinephrine 
remains unresolved. In a detailed study (Linsell et al.,  1985), a significant rhythm was 
reported in healthy subjects. However,  supine posture was assumed for only a few' 
minutes before each sample, and increases in plasma epinephrine associated with upright 
posture have been observed (Lake et al., 1984; Lake & Ziegler, 1985). Furthermore,  in 
three studies in which supine posture was maintained, the results were inconclusive. In one 
study (Aronow et al., 1978), only one of five subjects showed a significant fluctuation. In 
the second study (Ratge et  al.,  1982), a significant but small fluctuation ( -  20% to + 20% 
of the mean value) was observed, with the peak at mid-day and the trough at mid-sleep. In 
the third (Barnes et  al., 1980), the peak was approximately 200% of the trough; however, 
only two specimens, at 0400 hr and 2000 hr, were obtained. 
Parameters  of  plasma fluctuations have been studied. One study reported an ultradian 
(less than 24 hr) plasma norepinephrine fluctuation (Levin et al., 1979), but two others 
did not (Mullen et  al.,  1981; Linsell et al., 1985); epinephrine did not appear  to have an 
ultradian rhythm (Linsell et al., 1985). Several studies found no association between sleep 
stages and plasma norepinephrine levels (Brezinova & Carruthers,  1974; Prinz et al., 1979, 
1984; Stene et al., 1980; Mullen et al., 1981; Linsell et al.,  1985), and a similar tack of 
association between sleep stages and plasma epinephrine has been reported (Brezinova & 
Carruthers,  1974; Prinz et al.,  1979, 1984; Linsell et al., 1985). However,  only one of 
these studies involved healthy supine subjects (Stene et  al.,  1980), and this study did not 
examine epinephrine. Finally, covariation of the two catecholamines has been reported 
(Turton & Deegan, 1974; Ratge et al.,  1982; Linsell et al.,  1985). 
Since the existence of  a circadian fluctuation of resting plasma epinephrine remains 
ambiguous,  epinephrine levels were determined frequently in healthy subjects who 
remained strictly supine throughout the study. Furthermore,  neither the relationship 
between epinephrine levels and sleep nor the presence of ultradian fluctuations have been 
studied in supine subjects. In order to document  normal circadian fluctuations in these 
subjects, plasma norepinephrine and cortisol (Weitzman et  al.,  1971; Gallagher et al., 
1973) levels also were studied. Finally, as a further comparison with prior research, 




The subjects were four healthy drug-free men between the ages of 21 and 35. They neither smoked nor 
excessively used caffeinated beverages. All were on a normal night-time-sleep, day-time-awake circadian cycle 
prior to and during the study. The study was approved by the institutional human research review committee, 
and all subjects gave informed consent. 
Procedure 
Two experiments were performed. In Experiment I, frequent sampling of plasma catecholamines for 24 hr was 
done, together with EEG monitoring of sleep. In order to promote habituation to the eXl~dmental situation, the 
subjects slept with EEG leads in place in the sleep laboratory on the night before the study. On the day before, 
the subjects avoided strenuous exercise. The starting time was counterbalanced, with two subjects starting in the 
morning (one at 0800 hr and one at 1200 hr) and two in the evening (both at 2000 hr). The subjects had 
indwelling intravenous catheters for blood sampling, which ran into an adjoining room. They assumed a supme 
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posture in bed at least 1 hr before the study started; thereafter, they strictly maintained a supine posture 
throughout the experiment (the subjects had their heads raised 30 ° to eat, and they used a bedpan). EEG 
electrodes were in place throughout the study; recording of sleep EEG was done throughout the lights-out 
period. Lights were out from 2300 hr to 0700 hr and on at other times; sleep was not permitted when lights were 
on. Meals were served at 0800 hr, 1200 hr and 1800 hr on the study day. The diet avoided caffeinated beverages 
and other foods or beverages known to be high in substances which affect catecholamine levels; salt intake was 
ad libitum (Robertson et al., 1979; Stene et al., 1980). Seven ml blood specimens were obtained every 20 min for 
24 hr. In order to minimize specimen dilution or volume or red cell depletion through the duration of the study, 
the indwelling catheter was flushed of saline before each specimen was drawn; all flush blood was re-infused; 
and the volume was replaced with normal saline. The specimens were assayed for plasma epinephrine, 
norepinephrine, and cortisol, as described below. 
In Experiment Ii, urinary creatinine and unconjugated epinephrine and norepinephrine were measured twice 
for 24 hr. Three of the four subjects participated. Dietary control was the same as in Experiment !. During one 
of the 24 hr periods, the subjects maintained normal daily activities but avoided strenuous exercise. Urine was 
collected in four 4-hr aliquots and one 8-hr aliquot (0800-1200 hr, 1200-1600 hr, 1600-2000 hr, 
2000-2400 hr and 2400-0800 hr). During the other 24-hr period, urine was collected in two 12-hr aliquots, 
0800 2000 hr and 2000-0800 hr. The subjects remained supine for at least 6 hr before and throughout this 
period. Urine specimens were assayed for creatinine and unconjugated epinephrine and norepinephrine only; 
cortisol was not measured. 
The sleep EEG data included the standard central (C3) and occipital (OZ) electroencephalograms, 
electrooculogram, submental electromyogram, and electrocardiogram recorded with a V5 lead. Records were 
scored for sleep stages according to standard criteria (Rechtschaffen & Kales, 1968). 
Specimen analysis 
All urine specimens were collected in plastic bottles containing 5% acetic acid. The specimens were kept 
chilled during collection and then frozen until assay for epinephrine and norepinephrine. Blood for 
catecholamines was collected in chilled tubes containing reduced glutathione, an antioxidant, and EGTA, an 
anticoagulant; blood for cortisol was collected in chilled heparinized tubes. Plasma was separated within 10 min 
of collection and frozen until assay. Unconjugated epinephrine and norepinephrine in urine and plasma were 
assayed with a single-isotope radioenzymatic method (Peuler & Johnson, 1977; McCann & Huber-Smith, 1984). 
The assay sensitivity for both catecholamines is 20 pg/ml. Both the intra- and interassay coefficients of variation 
for norepinephrine are 11 °70, and for epinephrine 18%, based on sample contents of approximately 300 and 100 
pg/ml, respectively. Cortisol was determined with a competitive protein binding assay (Wilens et al., 1984). The 
assay sensitivity for cortisol is 0.4 ~tg/ml. The intra- and interassay coefficients of variation are both approx 707o. 
Creatinine in urine was determined by a colorimetric method with the "Rapid-Stat" kit. 
Statistical analysis 
Differences between subjects and between times, and the interaction of subjects by time, were determined. 
Because plasma levels of all three substances were demonstrated (by least squares regression analysis) to increase 
from the first to the last specimen drawn from each subject in Experiment I, analyses of covariance were 
performed in which these trends were removed statistically, and then differences of residual values were 
evaluated. A repeated-measures analysis of variance then was performed on these residuals. A multiple 
regression analysis also was performed, which additionally permitted tests of significance of sine and cosine 
components of the regression. A significant result indicated that a regular cyclical fluctuation in the data over 
24 hr was present (Harris, 1975). Pearson product-moment  correlations were calculated for each pair of 
hormones. Analyses of variance with two variables, subjects and time, were used in Experiment 11. 
Spectral analyses were performed within each subject and substance in Experiment I to determine if ultradian 
rhythms were present. Spectral analysis is a form of time series analysis by which data can be examined for 
consistent periodic fluctuations of different frequencies (Chatfield, 1980). Also, spectral analyses across 
substances, with and without temporal phase changes between substances, were studied to determine if plasma 
levels were associated (i.e., in phase) with each other. Finally, comparisons were performed (by analysis of 
variance) for each substance during different sleep stages in Experiment I. 
RESULTS 
E x p e r i m e n t  I: 
T h r e e  o f  f o u r  sub j ec t s  s h o w e d  s ta t i s t i ca l ly  s i g n i f i c a n t  t e n d e n c i e s  fo r  p l a s m a  
e p i n e p h r i n e  levels to  i nc r ea se  f r o m  the  f i rs t  to  t he  las t  s p e c i m e n  ( r e g r e s s i o n  ana lys i s ,  
p < 0 .0005,  0 .002,  a n d  0.05).  T h e r e f o r e ,  t h e s e  t r e n d s  w e r e  r e m o v e d  by  a n a l y s e s  o f  
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covariance. Substantial sample-to-sample variation was observed (Fig. 1). Although a 
decrease in mean level for the four subjects appears to have occurred at 0100 to 0200 hr, 
no statistically significant circadian fluctuation was demonstrated with either the 
repeated-measures or the regression analyses (Fig. 2). Sleep was normal in all four 
subjects. No ultradian rhythm or relation to sleep or sleep stage (Table 1) was observed. 
Two of  four subjects showed highly significant increases from the first to the last 
norepinephrine specimen (regression analysis, p < 0.0002) and one other showed a trend 
(p < 0.07). Therefore,  subsequent analyses again were performed on detrended data. By 
regression analysis, a significant difference over time for the mean level of  the four 
subjects at each time point was observed (p  < 0.01), with a significant cosine component  
(p < 0.01) but no significant sine component .  The highest values were in the late morning 
and the lowest just after midnight (Fig. 2). However,  the repeated-measures analysis was 
not statistically significant. Regression analyses for individual subjects indicated that one 
had a significant fluctuation (p  < 0.02) and a second showed a trend (p < 0.08), but two 
others were not significant. Interestingly, the subject with the least fluctuation had the 
highest mean 24-hr norepinephrine levels. For the mean of the four subjects, the 
amplitude was small, with the peak being only 165°70 of  the trough. No association with 
sleep stage was observed (Table I). All four subjects demonstrated ultradian rhythm peaks 
at 0.25, with spectral densities ranging f rom 2.0 to 4.9, suggesting an ultradian rhythm for 
norepinephrine of approximately 80 min. Two subjects also had peaks at 3 hr and two at 
11 hr. 
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FIG. 1. Individual plasma epinephrine (E) values (pg/ml) every 20 min from each of four normal subjects, with 
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FIG. 2. Circadian pattern of plasma cortisol (Cort, p.g/dl, panel A), norepinephrine (NE, pg/ml, panel B), and 
epinephrine {E, pg/m], panel C) (mean _+ S.E.M.) from 1200 hr (noon-N) to 1200 hr. Thick black line on 
abscissa is time of lights out. Each hourly point is the mean of ]2 data points--three values at 20-rain intervals 
for each of four subjects. 
Cortisol also demonstrated a highly-significant variation over time (for both analyses, 
p < 0.0001), without significant rises from the first to the last specimen (Fig. 2). In 
agreement with prior research (Weitzman et al., 1971; Gallagher et al., 1973), the lowest 
level was at 0100 hr and the highest at 0600 hr. Thus, the levels observed for 
norepinephrine and cortisol document normal endocrine functioning in these subjects 
under the conditions of this study. As with the catecholamines, no significant association 
with sleep or sleep stage for cortisol (Table I) was observed, and, similar to epinephrine, 
cortisol showed no ultradian rhythm. 
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Sleep stage A'aakc REM NREM 1 NR|-.M 2 
N 214 13 17 4S 
Epinephrine (pg/ml) ~ 1.99 7.02 k 6. I(I 9 11 
Norepinephrine (pg/ml} ,- 5.34 + 29.83 .... 27.71 2t 3~ 
Cortisol (~tg/dl) 0.12 + 3.27 + 0.82 0.66 
Sleep stages include REM (rapid eye movement) and NREM (non-REM) stages 1 and 2 through 4 combined. 
N represents the total number of observations from all four subjects of Experiment 1 in each stage. The scores 
represent mean differences per determination above ( + )  or below ( } the overall grand means for each 
hormone. Although there appears to be a difference between REM and NREM for norepinephrine, and REM vs 
other times for cortisol, none of the differences are statistically significant. Mean total sleep time for the four 
subjects ~as 7.0 hr. 
Correlations were performed between the three pairs of  hormones studied over time, 
separately for each subject and also for the mean of  all four subjects at each time point. In 
order to reduce within-subject variability between specimens, the means of three 
consecutive specimens for each subject (i.e., over 1 hr} were used. The correlations for 
individual subjects ranged from - 0 . 0 9  to - 0 . 7 0  for epinephrine × norepinephrine, 
- 0 . 0 2  to +0.48 for cortisol x norepinephrine, and -0 .1 7  to +0.15 for cortisol x 
epinephrine. The correlations for the combined data of  all four subjects were + 0.62 
(p < 0.002), + 0.46 (p < 0.02), and + 0.30 (p < 0.20), for the same three comparisons, 
respectively. Thus, at least for the aggregate data, the levels of  these substances are in 
phase with each other, although for cortisol x epinephrine the correlation was only 
weakly positive and not significant. Similarly-calculated correlations with phase shifts of 
up to 3 hr between all pairs of  substances produced only weaker correlations. 
Experiment H 
Twenty-four hr urinary unconjugated epinephrine and norepinephrine, and creatiaine, 
were collected as one 8-hr and four 4-hr aliquots. Creatinine levels indicated that urine 
collections were complete. For  data analysis the catecholamine levels for the 8-hr a i r  uots 
were divided by two in order to produce five 4-hr estimates of  urinary epinephrine and 
norepinephrine throughout 24 hr. 
With normal posture and variations in rest/activity, there was a trend towa.'d a 
circadian fluctuation of  urinary epinephrine (p < 0.10), with the peak being 
approximately 250°7o of  the trough (Fig. 3). The peak appeared in the late morning or 
early afternoon and the trough at night. Significant inter-subject differences were 
observed (p < 0.001). The peak level for urinary norepinephrine occurred in the 
afternoon, with the peak almost 250°7o of  the trough (Fig. 3}. This difference over time 
showed a weak trend toward significance (p  < 0.15). For norepinephrine as well, tl ere 
was a significant difference between subjects (p < 0.005). 
In order to study the effects of  posture and activity and to make comparisons w~z;, the 
results of  Experiment I, the circadian variation in urinary catecholamines while subjects 
remained supine also was determined. Creatinine levels again indicated that urine 
collections were complete. Mean urinary epinephrine showed a trend toward significance 
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for daytime levels to be greater than night levels (p < 0.10), even though the magnitude 
was small (Fig. 3). Norepinephrine also was higher during the day than at night. However, 
the magnitude of the difference again was small and, due to variation across individuals, 
not significant. A significant difference between subjects was observed for epinephrine 
(p < 0.05), but not for norepinephrine. These data are in agreement with prior findings 
that day-time urinary catecholamine levels are higher than night-time levels, even when 
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FIG. 3. Urinary unconjugated norepinephrine (NE) and epinephrine (E) in I.tg per collection (mean _+ S.E.M.) for 
four 4-hr ( 1 - 4 )  and one 8-hr (5) collections, 0800-1200,  1200-1600, 1600-2000, 2000-2400, and 
0000-0800 hr, respectively, appear in panel A (I.tg for collection 5 is one-half of  complete 8-hr collection, in 
order to make all five collections comparable). Subjects were engaged in normal ambulant activities. Urinary 
unconjugated NE and E in two 12-hr collections, 0800 - 2000 hr (a.m.) and 2000-  0800 hr (p.m.) from the same 
three subjects who remained supine, appear in panel B. 
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Large differences were observed between the urinary levels of epinephrine and 
norepinephrine when normal activity and posture was maintained compared to when 
supine posture was maintained. For the day-time 12-hr period 0800 hr -2000  hr, the 
average epinephrine level across subjects was 1.38 t~g supine vs 7.01 ~tg during normal 
activity (a 508°7o difference). For night-time epinephrine, the supine value was 0.86 I-tg vs 
3.44 I~g for normal activity (a 400°7o difference). For day-time norepinephrine, the values 
were 2.53 p.g supine vs 16.46 I.tg for normal activity (651%), while during the night the 
results were 2.12 ~tg supine vs 8.98 p.g for normal activity (424%). Thus, maintenance of 
upright posture and normal activity raised urinary levels of both catecholamines 
substantially, even in the night-time specimens when supine position was maintained part 
of the time. 
D I S C U S S I O N  
In these experiments, circadian changes in epinephrine levels in healthy young adult 
male humans were studied. Normal levels of norepinephrine and cortisol indicate normal 
functioning of these subjects. 
In contrast to a detailed previous study of plasma epinephrine (Linsell et  al . ,  1985), and 
also in contrast to most other hormones studied (Krieger, 1979), a significant circadian 
rhythm of epinephrine in plasma was not demonstrated in our study. A comparison of the 
two studies suggests a reason: in the prior study, subjects were not constantly supine. 
They " . . .  kept to a fixed activity regimen. They sat quietly for 10 minutes before 
sampling, then walked around the ward for at least 10 of the following 20 minutes". Prior 
studies have demonstrated that acute postural change influences plasma epinephrine. 
Furthermore, both the present study and prior studies have demonstrated that upright 
posture and normal activity produce a very substantial (approx. five-fold) increase in 
urinary excretion of epinephrine and norepinephrine (Karki, 1956; Townshend & Smith, 
1973). Thus, it is possible that postural and, especially, activity differences over several 
hours modified the levels of epinephrine and that this procedural difference accounted for 
the appearance of a significant epinephrine peak in the late afternoon and a trough at 
night in the prior study (Linsell et al . ,  1985). The appearance of a brief drop in plasma 
epinephrine between 0100 hr and 0200 hr for the average of the four subjects in our study 
seems to suggest a slight tendency for a drop at night in supine subjects, which was also 
suggested by some of the prior studies in supine subjects. However, inspection of the data 
from individual subjects (Fig. 1) does not reveal a consistent drop at these times. 
Furthermore, in the study of Prinz et  al. (1984), which also examined circadian 
fluctuations of plasma epinephrine, "a  supine position was encouraged throughout and 
was required in the 15 minutes preceding blood sampling". This study of supine subjects 
also failed to demonstrate a significant circadian variation. Thus, it appears that, if there 
is any circadian rhythm of plasma epinephrine, it is very weak, and that posture and 
activity may either produce a circadian pattern or accentuate the very weak one already 
present. Also, metabolic and/or  kidney functioning appears to produce a tendency 
towards a rhythm of cateeholamine appearance in urine, even in supine subjects, and this 
rhythm also may be accentuated by activity and/or  postural change (DeSchaepdryner & 
Leroy, 1961; Hollister & Moore, 1970; Froberg et  a l . ,  1972; Townshend & Smith, 1973; 
Faucheux et  al . ,  1976). 
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Several other findings are of interest. No ultradian pattern or association with sleep or 
stage of sleep was observed for epinephrine; this agrees with the prior studies reviewed 
above. Furthermore, the data of Experiment I indicated that norepinephrine levels are 
significantly correlated with both cortisol and epinephrine across all four subjects. One 
could hypothesize that norepinephrine levels may be influencing the other substances, but 
prior research indicates that this is not correct. Infusion of norepinephrine lowers cortisol 
(Wilcox et al., 1975; Few et al., 1980), and negative correlations between cortisol and 
norepinephrine plasma levels have been reported (Sotsky et al., 1981). Further, systemic 
treatment with dexamethasone, a synthetic glucocorticoid, lowers norepinephrine (Stene 
et al., 1980). Thus, it seems more likely that cortisol and norepinephrine levels correlate 
because their fluctuations are in phase but not directly dependent on each other. Since a 
circadian fluctuation for epinephrine was not observed, this explanation does not seem 
adequate for the norepinephrine- epinephrine correlation. However, the combination of 
a possible slight fluctuation for epinephrine, with the lowest point at the same time as 
norepinephrine, plus the stress effects described below, which would be in phase for each 
individual subject, might account for the observed correlation. Further study will be 
necessary to determine if systemic norepinephrine levels directly influence epinephrine 
levels, or vice versa. 
Another observation of interest relates to potential stress effects. Stress of various kinds 
increases systemic levels of epinephrine and norepinephrine. All subjects described the 
procedure of Experiment I as somewhat stressful (e.g., mild pain in the arm from which 
blood was drawn during the later part of the 24-hr period), even though cortisol levels 
were not obviously increased. Because start times for subjects were counterbalanced, this 
increase should not have influenced any circadian rhythm effect. But it might have 
increased the estimate of basal plasma levels of both catecholamines averaged over the 
24-hr period. For plasma epinephrine the magnitude of this potential stress effect, 
calculated as the mean of the last specimen obtained from each subject minus the mean of 
the first, divided by two, was approx. 48 pg/ml. Subtraction of this value from the levels 
observed (Fig. 2) would reduce the true basal epinephrine level to 10 pg/ml or less. If 
epinephrine is a stress hormone, secreted from the adrenal medulla only under stressful 
conditions, a true basal level this low might not be implausible. However, it is below 
previously reported studies [indeed, below the limit of reliability of existing assays (Peuler 
& Johnson, 1977; Holly & Makin, 1983; McCann & Huber-Smith, 1984)l; therefore, this 
result should be interpreted cautiously. 
For plasma norepinephrine, the magnitude of this stress effect was approximately 
44 pg/ml. Subtraction of these values from the basal ranges observed (Fig. 2) suggests 
that norepinephrine ranges between approx. 150 pg/ml and 250 pg/ml over the 24-hr 
period in unstressed individuals; this is in the lower range of the basal plasma 
norepinephrine levels reported previously in normal subjects (Lake el al., 1976; Cryer, 
1980; Stene et al., 1980; Ratge et al., 1982; Holly & Makin, 1983; McCann & Huber- 
Smith, 1984), suggesting that it is an appropriate estimate. 
The lack of a significant circadian fluctuation for plasma epinephrine in the unstressed 
(or, possibly in the case of this study, in a mildly stressed) state should not necessarily be 
extrapolated to more stressful conditions. It has been observed in rats that, even though 
no circadian fluctuation in plasma epinephrine level was observed in an unstressed 
situation, when a stressful circumstance (footshock) was introduced, the plasma levels of 
epinephrine did show circadian variation (McCarty et  al . ,  1981). The possibility of 
procedurally-related stress-induced elevations of catechotamines, as well as modifications 
of circadian patterns, should be considered in all studies of catecholamine levels. 
The present study included only males of a specific, relatively narrow age range; 
extrapolations to females or to other age groups should be done cautiously. Some 
hormone levels are different between males and females, although catecholamines appear 
not to be (Karki, 1956; Stene et al . ,  1980), and some show different levels in different age 
groups, including plasma norepinephrine (Lake et  al . ,  1976; Prinz et  al . ,  1979, 1984; 
Barnes et  al . ,  1982; Pfeifer et  al . ,  1983) but not epinephrine (Barnes et  al . ,  1982; Pfeifer et  
al . ,  1983; Prinz et  al . ,  1984). Finally, even with this homogeneous experimental group, 
significant and substantial differences for plasma catecholamine levels between subjects 
were observed. Such large inter-subject differences are consistent with prior studies (Lake 
et  al . ,  1984). 
The results of  this and prior research indicate that norepinephrine probably has a small 
amplitude circadian fluctuation in supine subjects, and that epinephrine has either no 
rhythm or a very small amplitude rhythm; troughs were during the night. Neither sleep 
nor sleep stage had an effect, and no ultradian epinephrine rhythm was observed. 
Norepinephrine may have an ultradian rhythm between 1.3 and 3 hr. However, no 
attempt was made to remove "Zeitgebers" (temporal stimuli or signals) such as 
l i ght -dark  cycle, sleep, or standard meal times; the results might have been different if 
this had been done. 
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